Needham & Company analyst Matt Matson initiates coverage on CryoLife (NYSE: CRY) with a Hold rating.The analyst comments "CRY has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage